Welcome to our dedicated page for ReposiTrak SEC filings (Ticker: TRAK), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page provides access to U.S. Securities and Exchange Commission filings for ReposiTrak, Inc. (NYSE: TRAK), a Nevada corporation that operates a cloud-based food traceability, compliance and supply chain data platform. Through these filings, investors can review how the company reports its financial results, corporate actions and governance matters in accordance with SEC requirements.
ReposiTrak’s recent Form 8-K filings include disclosures about quarterly cash dividend declarations on its common stock, authorization of a 10b5-1 share repurchase program under a broader repurchase authorization, earnings releases for fiscal quarters and years, and the results of its annual meeting of stockholders. These current reports also reference attached press releases and earnings call transcripts that provide additional detail on financial performance, capital allocation and operational commentary.
In addition to current reports, ReposiTrak files periodic reports such as Form 10-K annual reports and Form 10-Q quarterly reports, which contain audited or reviewed financial statements, management’s discussion and analysis, risk factor disclosures and information on its business, including its focus on food traceability, regulatory compliance and supply chain solutions delivered through cloud-based applications.
Stock Titan’s filings page is designed to surface these documents as they are made available on EDGAR and to pair them with AI-powered summaries that explain the key points in accessible language. Users can quickly identify items such as dividend announcements, share repurchase authorizations, earnings results and shareholder meeting outcomes, and then drill into the underlying SEC reports for more detail. This same interface can also be used to monitor insider and executive transactions reported on forms such as Form 4, as those become available for ReposiTrak insiders.
Randall K. Fields, identified as Chief Executive Officer, director and a >10% owner of ReposiTrak, Inc. (TRAK), reported a series of open-market sales of the company's common stock executed 09/15/2025–09/17/2025. The Form 4 discloses three reported sales under a Rule 10b5-1 trading plan established by Fields in his capacity as trustee of the 2022 RK Fields Charitable Remainder Unitrust to satisfy charitable commitments. The reported transactions: 3,000 shares sold on 09/15/2025 at a weighted average price of $17.0201, 1,965 shares on 09/16/2025 at $17.0026, and 2,535 shares on 09/17/2025 at $17.2325. The footnotes state the shares were sold in multiple transactions at prices ranging from $16.97 to $17.65 and that the reporting person will provide breakouts by price on request.
Randall K. Fields, reported a sale of 7,500 shares of ReposiTrak, Inc. (TRAK) common stock on 09/08/2025 under a Rule 10b5-1 trading plan. The Form 4 states a weighted average price of $16.0594 for the reported sale and a footnote discloses that the shares were sold in multiple transactions at prices ranging from $17.076 to $17.38. The filing explains the trading plan was adopted by Mr. Fields in his capacity as trustee to satisfy charitable commitments.
The filing also lists beneficial ownership stakes across several entities and relationships, including 3,683,955 shares (listed as direct), 615,260 shares indirect via Riverview Financial Corp., 30,667 shares indirect by spouse, and 79,500 shares indirect by RK Fields Charitable 2022, LLC following the reported transaction. Multiple entries show indirect holdings through Fields Management, Inc. and Riverview Financial Corp., and ownership of Series B preferred shares.
Randall K. Fields, CEO, Director and 10% owner of ReposiTrak, Inc. (TRAK), reported multiple sales of company common stock over August 25-27, 2025. According to the Form 4, 2,000 shares were sold on 08/25/2025 at a weighted average price of $16.4155, 1,500 shares on 08/26/2025 at a weighted average price of $15.83, and 4,000 shares on 08/27/2025 at a weighted average price of $15.8915, for a total of 7,500 shares disposed. The filings state these sales occurred automatically under a Rule 10b5-1 trading plan established by the reporting person in his capacity as trustee to meet charitable commitments.
The Form 4 also lists beneficial ownership positions across related entities and persons, including direct and indirect holdings reported in the form.
Randall K. Fields, a director, 10% owner and CEO of ReposiTrak, Inc. (TRAK), reported an automatic sale of 7,500 shares of the issuer's common stock on 08/18/2025 at a weighted average price of $16.6289 per share under a Rule 10b5-1 trading plan. The filing shows the sale was executed by RK Fields Charitable 2022, LLC in its capacity tied to a charitable remainder unitrust. The Form 4 lists post-transaction beneficial holdings across several accounts, including 3,683,955 shares held directly and additional indirect holdings reported via Riverview Financial Corp., spouse, Fields Management, Inc., and related Series B preferred positions.
Randall K. Fields, who serves as Chief Executive Officer, Director and a 10% owner of ReposiTrak, Inc. (TRAK), reported insider sales executed under a Rule 10b5-1 trading plan adopted to satisfy charitable commitments. The filing shows two automated sales totaling 7,500 common shares: 4,000 shares on 08/11/2025 at a weighted average price of $16.8251 and 3,500 shares on 08/12/2025 at a weighted average price of $16.836.
The Form 4 also lists the reporting person's disclosed holdings across direct and indirect vehicles: 3,683,955 shares directly, indirect common-stock interests held by Riverview Financial Corp. (615,260), spouse (30,667), and Fields Management, Inc. (333,643), plus Series B preferred holdings attributed to Riverview (531,432) and spouse (12,322).
ReposiTrak (TRAK) Form 4: CEO, Chairman & 10% owner Randall K. Fields disclosed the automatic sale of 7,500 common shares on 7/28-7/30/2025 under a pre-arranged Rule 10b5-1 plan enacted to fund charitable commitments. Sales were executed by the 2022 RK Fields Charitable LLC at VWAPs of $18.27, $18.10 and $17.11, generating roughly $135k gross proceeds.
After the transactions, the charitable LLC still holds 124,500 shares. Including other direct and indirect holdings, Fields retains significant ownership:
- Direct: 3,683,955 common shares
- Indirect: 615,260 (Riverview Financial Corp.), 333,643 (Fields Management Inc.), 30,667 (spouse)
- Series B preferred: 543,754 indirect cumulative
No derivative activity or option exercises were reported. The filing signals modest insider selling (≈0.16% of reported common holdings) rather than a major ownership reduction, and the 10b5-1 structure limits discretionary market timing.
FAQ
What is the current stock price of ReposiTrak (TRAK)?
What is the market cap of ReposiTrak (TRAK)?
